Table 2.
Group | Age (years) | Duration of sexual abstinence (days) | Volume (ml) | Concentration (X 106/ml) | Morphologically normal sperm (%) | Total progressive motility (%) | DNA fragmentation (% TUNEL positive spermatozoa) | % Chromomycin A3 positive spermatozoa | |
---|---|---|---|---|---|---|---|---|---|
Patients Group1 | (mean±SD) | 31.9 ± 2.4 | 4.1 ± 0.2 | 3.2 ± 1.0 | 3.3 ± 2.3 | 7.9 ± 2.8 | 23.9 ± 9.6 | 26.3 ± 5.3 | 27.5 ± 7.9 |
(n = 30) | Range | 24–34 | 4–5 | 0.5–5.0 | 0.8–9.0 | 2.0–13.0 | 0.0–33.0 | 19.4–40.6 | 11.6–41.6 |
Patient Group2 | (mean±SD) | 41.6 ± 5.4 | 4.2 ± 0.4 | 2.6 ± 1.0 | 5.0 ± 2.7 | 5.8 ± 2.7 | 19.2 ± 8.0 | 33.7 ± 6.7 | 35.4 ± 8.2 |
(n = 31) | Range | 35–54 | 4–5 | 0.6–4.7 | 0.8–11.0 | 1.0–13.0 | 5.0–33.0 | 20.6–49.8 | 15.0–47.8 |
P (Mann–Whitney test) | P < 0.001 | NS (0.082) | P = 0.028 | P = 0.004 | P < 0.001 | P = 0.018 | P < 0.001 | P < 0.001 | |
Control Group1 | (mean±SD) | 30.3 ± 2.6 | 4.1 ± 0.3 | 3.3 ± 0.7 | 51.0 ± 22.4 | 30.0 ± 8.0 | 56.5 ± 4.4 | 6.5 ± 1.9 | 6.5 ± 1.8 |
(n = 26) | Range | 24–34 | 4–5 | 2.1–4.6 | 22.0–106.0 | 15.0–45.0 | 50.0–70.0 | 3.4–12.6 | 3.4–11.4 |
Control Group2 | (mean±SD) | 39.3 ± 3.2 | 4.1 ± 0.3 | 3.4 ± 0.8 | 42.0 ± 14.0 | 27.8 ± 6.7 | 54.7 ± 4.1 | 5.9 ± 1.7 | 6.2 ± 1.8 |
(n = 23) | Range | 35–45 | 4–5 | 2.0–5.1 | 22.0–81.0 | 20.0–45.0 | 50.0–65.0 | 3.8–9.4 | 3.2–10.6 |
P (Mann–Whitney test) | P < 0.001 | NS (0.745) | NS (0.880) | NS (0.173) | NS (0.144) | NS (0.301) | NS (0.189) | NS (0.602) |
NS = not significant.